Avaí Bio and Austrianova began work with Ospedale San Raffaele on protecting lab-grown insulin cells from the immune system.

Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on ...

As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report ...

Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for ...

Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for ...

KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy ...

Cala Health’s kIQ Plus now offers three stimulation modes and a calibration before each use, and it’s available across the US ...

Shmouni and Koehl Robinson unpack peptide medicine, from GLP-1s and BPC-157 to evidence, safety, regulation and personalized ...

German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.

A day is a long time to study a donated human brain. Bexorg thinks it’s still too short. On 7 October, the Connecticut-based ...

Adjusting for how advanced patients’ disease was at the start lifts the Phase 2 result. The method was added after the trial ...

BodySpec’s new storefront targets muscle loss from GLP-1 weight loss drugs, with scans said to take about 12 minutes.